Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Illumina, Inc. (ILMN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Illumina, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1110803.
Total stock buying since 2005: $2,748,194.
Total stock sales since 2005: $1,191,574,365.
Total stock option exercises since 2005: $187,225,090.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 18,450 | $1,500,027 | 0 | $0 | 0 | $0 |
| 2024 | 7,330 | $996,344 | 0 | $0 | 0 | $0 |
| 2023 | 0 | $0 | 11,630 | $2,288,888 | 68,902 | $540,284 |
| 2022 | 0 | $0 | 6,787 | $2,313,640 | 38,110 | $0 |
| 2021 | 0 | $0 | 76,862 | $32,133,367 | 53,748 | $0 |
| 2020 | 0 | $0 | 153,063 | $51,235,027 | 107,230 | $0 |
| 2019 | 0 | $0 | 166,043 | $51,488,681 | 148,450 | $4,489,250 |
| 2018 | 0 | $0 | 207,105 | $59,766,035 | 152,950 | $3,491,285 |
| 2017 | 0 | $0 | 455,648 | $88,829,978 | 425,871 | $21,632,278 |
| 2016 | 0 | $0 | 304,789 | $48,921,636 | 545,401 | $8,014,616 |
| 2015 | 0 | $0 | 1,117,701 | $221,793,291 | 753,395 | $24,718,407 |
| 2014 | 0 | $0 | 1,302,250 | $215,660,563 | 1,262,640 | $37,615,935 |
| 2013 | 0 | $0 | 1,596,048 | $118,377,128 | 1,492,387 | $40,207,436 |
| 2012 | 1,217 | $47,458 | 186,591 | $9,547,988 | 206,000 | $3,823,781 |
| 2011 | 4,839 | $204,365 | 793,264 | $55,004,833 | 780,467 | $11,494,144 |
| 2010 | 0 | $0 | 1,462,467 | $65,282,978 | 1,178,143 | $16,880,360 |
| 2009 | 0 | $0 | 948,051 | $34,070,305 | 524,296 | $4,030,889 |
| 2008 | 0 | $0 | 999,177 | $62,564,210 | 426,200 | $4,917,923 |
| 2007 | 0 | $0 | 1,065,401 | $47,966,087 | 533,039 | $5,235,340 |
| 2006 | 0 | $0 | 553,233 | $17,611,673 | 28,700 | $133,162 |
| 2005 | 0 | $0 | 546,352 | $6,718,057 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-26 | Samad Sam (SVP and CFO) | Sale | 1,356 | 360.00 | 488,160 |
| 2020-05-20 | Tousi Susan H (SVP Product Development) | Sale | 300 | 350.00 | 105,000 |
| 2020-05-19 | Flatley Jay T (Director) | Sale | 4,000 | 342.34 | 1,369,360 |
| 2020-05-18 | Samad Sam (SVP and CFO) | Sale | 1,357 | 340.00 | 461,380 |
| 2020-05-12 | Tousi Susan H (SVP Product Development) | Sale | 600 | 325.00 | 195,000 |
| 2020-05-11 | Arnold Frances (Director) | Sale | 1,503 | 309.11 | 464,592 |
| 2020-05-11 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 2,140 | 315.13 | 674,369 |
| 2020-05-05 | Flatley Jay T (Director) | Sale | 3,000 | 310.37 | 931,110 |
| 2020-05-01 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 316.84 | 198,023 |
| 2020-05-01 | Dadswell Charles (SVP & General Counsel) | Sale | 121 | 317.16 | 38,376 |
| 2020-05-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 310.59 | 931,773 |
| 2020-04-21 | Flatley Jay T (Director) | Sale | 3,000 | 310.77 | 932,310 |
| 2020-04-20 | Samad Sam (SVP and CFO) | Sale | 1,356 | 320.02 | 433,947 |
| 2020-04-16 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 1,250 | 300.22 | 375,275 |
| 2020-04-16 | Samad Sam (SVP and CFO) | Sale | 1,697 | 300.00 | 509,100 |
| 2020-04-16 | Febbo Phillip G. (SVP Chief Medical Officer) | Sale | 173 | 300.00 | 51,900 |
| 2020-04-14 | Samad Sam (SVP and CFO) | Sale | 249 | 292.54 | 72,842 |
| 2020-04-07 | Flatley Jay T (Director) | Sale | 2,000 | 284.63 | 569,260 |
| 2020-04-06 | Desouza Francis A (President and CEO) | Sale | 3,000 | 275.00 | 825,000 |
| 2020-04-01 | Dadswell Charles (SVP & General Counsel) | Sale | 121 | 265.92 | 32,176 |
| 2020-03-05 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 417 | 273.95 | 114,237 |
| 2020-03-03 | Flatley Jay T (Director) | Sale | 2,000 | 277.40 | 554,800 |
| 2020-03-02 | Dadswell Charles (SVP & General Counsel) | Sale | 1,686 | 268.02 | 451,881 |
| 2020-03-02 | Desouza Francis A (President and CEO) | Sale | 3,000 | 275.00 | 825,000 |
| 2020-02-18 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 1,800 | 298.68 | 537,615 |
| 2020-02-18 | Flatley Jay T (Director) | Sale | 3,000 | 299.00 | 897,000 |
| 2020-02-11 | Tousi Susan H (SVP Product Development) | Option Ex | 9,969 | .00 | 0 |
| 2020-02-11 | Van Oene Mark (SVP Chief Commercial Officer) | Option Ex | 11,641 | .00 | 0 |
| 2020-02-11 | Samad Sam (SVP and CFO) | Option Ex | 6,626 | .00 | 0 |
| 2020-02-11 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Option Ex | 13,488 | .00 | 0 |
| 2020-02-11 | Dadswell Charles (SVP & General Counsel) | Option Ex | 7,624 | .00 | 0 |
| 2020-02-11 | Desouza Francis A (President and CEO) | Option Ex | 35,184 | .00 | 0 |
| 2020-02-11 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 11,728 | .00 | 0 |
| 2020-02-11 | Ragusa Robert P (SVP, Global Quality & Ops) | Option Ex | 9,969 | .00 | 0 |
| 2020-02-11 | Mcginnis Karen K (VP, Chief Accounting Officer) | Option Ex | 1,001 | .00 | 0 |
| 2020-02-05 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 300.24 | 187,650 |
| 2020-02-03 | Samad Sam (SVP and CFO) | Sale | 238 | 293.10 | 69,757 |
| 2020-02-03 | Ragusa Robert P (SVP, Global Quality & Ops) | Sale | 1,253 | 293.10 | 367,254 |
| 2020-01-06 | Tousi Susan H (SVP Product Development) | Sale | 200 | 325.00 | 65,000 |
| 2020-01-02 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 330.86 | 206,784 |
| 2019-12-10 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 1,200 | 326.01 | 391,212 |
| 2019-12-06 | Tousi Susan H (SVP Product Development) | Sale | 1,000 | 325.00 | 325,000 |
| 2019-12-02 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 320.15 | 200,093 |
| 2019-12-02 | Dadswell Charles (SVP & General Counsel) | Sale | 655 | 320.33 | 209,816 |
| 2019-11-29 | Samad Sam (SVP and CFO) | Sale | 892 | 320.00 | 285,440 |
| 2019-11-14 | Febbo Phillip G. (SVP Chief Medical Officer) | Sale | 155 | 300.00 | 46,500 |
| 2019-11-01 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 300.10 | 187,562 |
| 2019-11-01 | Dadswell Charles (SVP & General Counsel) | Sale | 193 | 297.28 | 57,375 |
| 2019-11-01 | Ragusa Robert P (SVP, Global Quality & Ops) | Sale | 1,674 | 297.28 | 497,646 |
| 2019-10-15 | Ronaghi Mostafa (SVP & CTO) | Sale | 4,000 | 311.34 | 1,245,364 |
| 2019-10-15 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 4,000 | 69.34 | 277,360 |
| 2019-10-01 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 304.84 | 190,524 |
| 2019-10-01 | Dadswell Charles (SVP & General Counsel) | Sale | 124 | 304.22 | 37,723 |
| 2019-09-16 | Ronaghi Mostafa (SVP & CTO) | Sale | 10,000 | 300.24 | 3,002,430 |
| 2019-09-16 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 10,000 | 69.34 | 693,400 |
| 2019-09-03 | Dadswell Charles (SVP & General Counsel) | Sale | 1,220 | 279.88 | 341,453 |
| 2019-08-28 | Flatley Jay T (Director) | Sale | 3,300 | 283.41 | 935,253 |
| 2019-08-15 | Ronaghi Mostafa (SVP & CTO) | Sale | 10,000 | 285.85 | 2,858,500 |
| 2019-08-15 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 10,000 | 69.34 | 693,400 |
| 2019-08-14 | Flatley Jay T (Director) | Sale | 3,300 | 288.36 | 951,588 |
| 2019-08-09 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 1,260 | 298.54 | 376,160 |
| 2019-08-08 | Ragusa Robert P (SVP, Global Quality & Ops) | Sale | 2,230 | 293.09 | 653,590 |
| 2019-08-01 | Dadswell Charles (SVP & General Counsel) | Sale | 124 | 300.00 | 37,200 |
| 2019-08-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 301.54 | 904,620 |
| 2019-07-24 | Flatley Jay T (Director) | Sale | 3,300 | 304.00 | 1,003,200 |
| 2019-07-15 | Ronaghi Mostafa (SVP & CTO) | Sale | 10,000 | 303.12 | 3,031,150 |
| 2019-07-15 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 10,000 | 69.34 | 693,400 |
| 2019-07-10 | Flatley Jay T (Director) | Sale | 3,300 | 376.50 | 1,242,450 |
| 2019-07-01 | Dadswell Charles (SVP & General Counsel) | Sale | 124 | 371.29 | 46,039 |
| 2019-07-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 369.43 | 1,108,281 |
| 2019-06-26 | Flatley Jay T (Director) | Sale | 3,300 | 358.15 | 1,181,895 |
| 2019-06-17 | Ronaghi Mostafa (SVP & CTO) | Sale | 10,000 | 349.15 | 3,491,520 |
| 2019-06-17 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 10,000 | 69.34 | 693,400 |
| 2019-06-12 | Flatley Jay T (Director) | Sale | 3,300 | 334.53 | 1,103,949 |
| 2019-06-10 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 1,260 | 335.03 | 422,137 |
| 2019-06-03 | Dadswell Charles (SVP & General Counsel) | Sale | 1,220 | 309.31 | 377,360 |
| 2019-06-03 | Desouza Francis A (President and CEO) | Sale | 3,000 | 309.61 | 928,815 |
| 2019-05-22 | Flatley Jay T (Director) | Sale | 3,300 | 304.44 | 1,004,652 |
| 2019-05-15 | Ronaghi Mostafa (SVP & CTO) | Sale | 10,000 | 304.91 | 3,049,060 |
| 2019-05-15 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 10,000 | 69.34 | 693,400 |
| 2019-05-13 | Arnold Frances (Director) | Sale | 1,503 | 307.95 | 462,848 |
| 2019-05-10 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 1,260 | 315.32 | 397,303 |
| 2019-05-08 | Flatley Jay T (Director) | Sale | 3,300 | 318.59 | 1,051,347 |
| 2019-05-01 | Dadswell Charles (SVP & General Counsel) | Sale | 124 | 311.77 | 38,659 |
| 2019-05-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 310.49 | 931,479 |
| 2019-05-01 | Epstein Robert S (Director) | Sale | 5,000 | 310.80 | 1,553,995 |
| 2019-05-01 | Epstein Robert S (Director) | Option Ex | 5,000 | 51.17 | 255,850 |
| 2019-04-24 | Flatley Jay T (Director) | Sale | 3,300 | 321.96 | 1,062,468 |
| 2019-04-10 | Flatley Jay T (Director) | Sale | 3,300 | 317.01 | 1,046,133 |
| 2019-04-01 | Dadswell Charles (SVP & General Counsel) | Sale | 124 | 314.45 | 38,991 |
| 2019-04-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 316.33 | 948,990 |
| 2019-04-01 | Epstein Robert S (Director) | Sale | 1,000 | 314.45 | 314,450 |
| 2019-04-01 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2019-03-27 | Flatley Jay T (Director) | Sale | 3,300 | 306.93 | 1,012,869 |
| 2019-03-13 | Flatley Jay T (Director) | Sale | 3,300 | 306.50 | 1,011,450 |
| 2019-03-01 | Dadswell Charles (SVP & General Counsel) | Sale | 1,220 | 313.93 | 382,994 |
| 2019-03-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 316.39 | 949,185 |
| 2019-03-01 | Epstein Robert S (Director) | Sale | 1,000 | 313.93 | 313,930 |
| 2019-03-01 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2019-02-27 | Flatley Jay T (Director) | Sale | 3,300 | 300.00 | 990,000 |
| 2019-02-26 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 298 | 304.63 | 90,779 |
| 2019-02-15 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Sale | 1,260 | 294.87 | 371,536 |
| 2019-02-13 | Flatley Jay T (Director) | Sale | 3,300 | 293.66 | 969,078 |
| 2019-02-12 | Ostadan Omead (SVP Mktg, Prod & Strat Plan) | Option Ex | 9,492 | .00 | 0 |
| 2019-02-12 | Dadswell Charles (SVP & General Counsel) | Option Ex | 4,127 | .00 | 0 |
| 2019-02-12 | Desouza Francis A (President and CEO) | Option Ex | 24,621 | .00 | 0 |
| 2019-02-12 | Ronaghi Mostafa (SVP & CTO) | Option Ex | 9,782 | .00 | 0 |
| 2019-02-12 | Ragusa Robert P (SVP, Global Quality & Ops) | Option Ex | 4,540 | .00 | 0 |
| 2019-02-12 | Flatley Jay T (Director) | Option Ex | 28,888 | .00 | 0 |
| 2019-02-01 | Dadswell Charles (SVP & General Counsel) | Sale | 124 | 280.11 | 34,733 |
| 2019-02-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 282.64 | 847,913 |
| 2019-02-01 | Epstein Robert S (Director) | Sale | 1,000 | 280.11 | 280,110 |
| 2019-02-01 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2019-01-23 | Flatley Jay T (Director) | Sale | 3,300 | 303.53 | 1,001,648 |
| 2019-01-09 | Flatley Jay T (Director) | Sale | 3,300 | 296.20 | 977,460 |
| 2019-01-02 | Dadswell Charles (Sr VP & General Counsel) | Sale | 124 | 294.71 | 36,544 |
| 2019-01-02 | Desouza Francis A (President and CEO) | Sale | 3,000 | 293.78 | 881,352 |
| 2019-01-02 | Epstein Robert S (Director) | Sale | 1,000 | 294.71 | 294,710 |
| 2019-01-02 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2019-01-02 | Eastham Karin (Director) | Sale | 5,000 | 294.03 | 1,470,170 |
| 2019-01-02 | Eastham Karin (Director) | Option Ex | 4,000 | 71.09 | 284,360 |
| 2018-12-26 | Flatley Jay T (Director) | Sale | 3,300 | 273.87 | 903,771 |
| 2018-12-12 | Flatley Jay T (Director) | Sale | 3,300 | 334.13 | 1,102,629 |
| 2018-12-10 | Ostadan Omead (EVP Ops, Products, Strategy) | Sale | 644 | 321.50 | 207,046 |
| 2018-12-06 | Stapley Marc (EVP Strategy & Corp Developmt) | Sale | 1,000 | 329.19 | 329,186 |
| 2018-12-03 | Dadswell Charles (Sr VP & General Counsel) | Sale | 566 | 343.57 | 194,460 |
| 2018-12-03 | Desouza Francis A (President and CEO) | Sale | 3,000 | 346.60 | 1,039,790 |
| 2018-12-03 | Epstein Robert S (Director) | Sale | 1,345 | 343.57 | 462,101 |
| 2018-12-03 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2018-11-28 | Flatley Jay T (Director) | Sale | 3,300 | 321.80 | 1,061,940 |
| 2018-11-23 | Ostadan Omead (EVP Ops, Products, Strategy) | Sale | 644 | 306.74 | 197,540 |
| 2018-11-14 | Flatley Jay T (Director) | Sale | 3,300 | 312.50 | 1,031,250 |
| 2018-11-12 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 10,000 | 317.38 | 3,173,790 |
| 2018-11-12 | Ronaghi Mostafa (Sr VP & CTO) | Option Ex | 10,000 | 37.04 | 370,400 |
| 2018-11-07 | Stapley Marc (EVP Strategy & Corp Developmt) | Sale | 1,000 | 335.86 | 335,864 |
| 2018-11-05 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 6,835 | 326.06 | 2,228,613 |
| 2018-11-05 | Van Oene Mark (SVP Chief Commercial Officer) | Option Ex | 6,000 | 29.44 | 176,640 |
| 2018-11-01 | Desouza Francis A (President and CEO) | Sale | 2,100 | 310.95 | 652,990 |
| 2018-11-01 | Epstein Robert S (Director) | Sale | 1,346 | 311.86 | 419,763 |
| 2018-11-01 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2018-10-24 | Flatley Jay T (Director) | Sale | 3,300 | 310.58 | 1,024,914 |
| 2018-10-10 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 10,000 | 313.56 | 3,135,610 |
| 2018-10-10 | Ronaghi Mostafa (Sr VP & CTO) | Option Ex | 10,000 | 37.04 | 370,400 |
| 2018-10-10 | Flatley Jay T (Director) | Sale | 3,300 | 321.58 | 1,061,214 |
| 2018-10-01 | Desouza Francis A (President and CEO) | Sale | 2,100 | 370.08 | 777,174 |
| 2018-10-01 | Epstein Robert S (Director) | Sale | 1,346 | 369.15 | 496,875 |
| 2018-10-01 | Epstein Robert S (Director) | Option Ex | 1,000 | 51.17 | 51,170 |
| 2018-09-26 | Flatley Jay T (Director) | Sale | 3,300 | 360.81 | 1,190,673 |
| 2018-09-12 | Flatley Jay T (Director) | Sale | 3,300 | 351.66 | 1,160,478 |
| 2018-09-10 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 10,000 | 346.35 | 3,463,450 |
Insider trading activities including stock purchases, stock sales, and option exercises of ILMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Illumina, Inc. (symbol ILMN, CIK number 1110803) see the Securities and Exchange Commission (SEC) website.